maldi-tof ms method (Bruker Corporation)

Bruker Corporation is a verified supplier

Bruker Corporation manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Bruker Corporation maldi-tof ms method
Maldi Tof Ms Method, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/maldi+tof+method/d8+advance+diffractometer/pmc12171570-61-9-9
Average 90 stars, based on 1 article reviews

maldi-tof ms method - by Bioz Stars, 2026-10

90/100 stars

Images

other:

Article Title: Treatment of bone and joint infections caused by Enterobacter cloacae with a fluoroquinolone-cotrimoxazole combination.
Article Snippet: Although the frequency of bone and joint infection caused by Enterobacter spp is increasing, studies regarding the optimal antibiotic therapy are scarce.. The objective of the current retrospective study was to assess the clinical outcomes and safety of a fluoroquinolonecotrimoxazole combination for the treatment of bone and joint infections caused by E. cloacae.. Between 2010 and 2017, 30 patients with bone and joint infection caused by E. cloacae were treated with a fluoroquinolone-cotrimoxazole combination for 8 to 12 weeks.

Article Title: 2-(Cyclopropylamino)-5-(4-methoxybenzylidene)thiazol-4(5H)-one
Article Snippet: Reference and clinical microbial strains that had been previously identified using the 16S rRNA gene and the MALDI TOF method (Bruker, Bremen, Germany) were applied.

Article Title: Evaluation of imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam and cefepime-zidebactam activities on a wide collection of French clinical Enterobacterales isolates.
Article Snippet: In recent years, novel β-lactam-inhibitor combinations (imipenem-relebactam (I/R), meropenem-vaborbactam (M/V), aztreonam-avibactam (A/A)) have been commercialized and some are not yet on the market (cefepime-zidebactam (C/Z)).. The objective of this study was to evaluate the efficacy of these β-lactam-β-lactamase inhibitors (BL/BLIs) combinations against a wide collection of French clinical multiresistant Enterobacterales isolates and to assess the performance of the E-test MIC method for I/R and M/V.. BL/BLIs MICs were determined by broth microdilution on a collection of 200 ESBL-producing and 414 carbapenem-resistant clinical Enterobacterales (K. pneumoniae (271), E. coli (245), E. cloacae complex (48), other * Corresponding author at: Laboratoire de Bactériologie, CHU Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France.

Article Title: Bone and joint infections caused by Clostridium perfringens: a case series.
Article Snippet: The objective of this study was to evaluate antimicrobial therapy outcomes of bone and joint infections (BJI) caused by Clostridium perfringens.. We investigated remission of symptoms and the absence of relapse or reinfection during followup.. Among the 8 patients with C. perfringens BJI, the type of infection was early prosthesis infection (n = 2), osteosynthetic device infection (n = 4), and chronic osteomyeletis (n = 2).

Article Title: Gonococci – Pathogens of Growing Importance. Part 1. Current Data on Diagnostics, Genotyping and Therapy.
Article Snippet: Buchanan et al. (2016) conducted a retrospective analysis of the identification results of 1,090 gonococci by two methods: manual, biochemical using API NH assays (bioMerieux) and spectrometric using the SepsiTyper system (Bruker) or VITEK MS (bioMerieux), estimated the positive predictive value for the MALDI TOF method at 99.3%.

Clinical Proteomics:

Article Title: Cryptococcus gattii in Patients with Lymphoid Neoplasms: An Illustration of Evolutive Host–Fungus Interactions
Article Snippet: Cryptococcus antigen (CALAS, Meridian Bioscience) was positive in the CSF (titre of 11) and in the serum (titre of 19). .. Fungal cultures of the CSF were positive and the MALDI-TOF method (Bruker Biotyper) allowed identification of the species Cryptococcus gattii . .. Genotyping was performed by multilocus sequence typing (MLST) at the French National Reference Center for Invasive Mycoses and Antifungals (NRCMA), using the ISHAM-7 loci scheme and comparisons with the online database ( http://mlst.mycologylab.org/page/CG%20 , main accessed on 22 October 2020) [ ], which led to the identification of Cryptococcus gattii serotype B, belonging to the molecular clade VGI, genotype ST197.

Analysis:

Article Title: Mechanisms of Resistance to Clinically Significant Antibiotics in Bacillus Strains Isolated from Samples Obtained from a Medical Institution
Article Snippet: Isolates of bacterial strains dominating on the surface of medical equipment used for blood sampling have been studied.. Pure cultures of these bacteria have been identified as Bacillus cereus HSA01, Bacillus cereus HSA12, Bacillus cereus HSA03, Bacillus subtilis HSA06, and Bacillus amyloliquefaciens HSA09, and their resistance to a number of β-lactam antibiotics and spectinomycin has been determined.. All strains are shown to be resistant to penicillin and ampicillin with the minimum inhibitory concentration (MIC) varying from 256 to 2048 μg/mL as well as to cephalosporin antibiotics with the MIC values varying from 2 to 2048 μg/mL.

Isolation:

Article Title: Effect of O-acetylation of O antigen of Escherichia coli lipopolysaccharide on the nonspecific barrier function of the outer membrane
Article Snippet: ⎯Comparison of the methods for determination of permeability of the outer membrane of Escherichia coli strain 4s and its mutants was carried out.. The studied isogenic strains E. coli 4s were obtained by selection of spontaneous mutants according to their sensitivity to bacteriophages recognizing the surface O antigen of the outer membrane lipopolysaccharide as a primary receptor.. The variants differed in the presence and (de)acetylation of the lipopolysaccharide O antigen.

Review